Press "Enter" to skip to content

New patent for Astrazeneca Ab drug FARXIGA

0
Copyright © DrugPatentWatch. Originally published at New patent for Astrazeneca Ab drug FARXIGA

Annual Drug Patent Expirations for FARXIGA
Annual Drug Patent Expirations for FARXIGA

Farxiga is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from three suppliers. There are eighteen patents protecting this drug and one Paragraph IV challenge.

FARXIGA drug price trends.

Drug patent litigation for FARXIGA.

This drug has three hundred and twenty-two patent family members in forty-six countries.

The generic ingredient in FARXIGA is dapagliflozin. Three suppliers are listed for this compound. Additional details are available on the dapagliflozin profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Astrazeneca Ab drug FARXIGA
    Get the DrugPatentWatch Daily Briefing

    ✓ Patent Expirations and Generic Entry

    ✓ Insightful Articles & Case Studies

    ✓ Patent Litigation & Challenges

    ✓ 505(b)(2) & Biosimilars

    ✓ Industry Trends

    DrugPatentWatch - Make Better Decisions